Prices for the majority of drugs in the U.S. have started to rise more slowly, likely a result of public and political pressure, according to a five-year study released Tuesday by drug pricing startup GoodRx.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,